Lv31
304 积分 2024-03-29 加入
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
2小时前
已完结
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
3小时前
已完结
MTClin: Integrating MammaTyper® to predict neoadjuvant therapy response in HER2+ breast cancer
4小时前
已完结
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes
5小时前
已完结
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
5小时前
已完结
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
7天前
已完结
Report of the forth Asian Prostate Cancer (A-CaP) study meeting
11天前
已完结
Sodium‐glucose co‐transporter‐2 inhibitors and major adverse limb events: A trial‐level meta‐analysis including 51 713 individuals
2个月前
已完结
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis
2个月前
已完结
European Study of Prostate Cancer Screening — 23-Year Follow-up
7个月前
已完结
皖公网安备34019202002308
